#BEGIN_DRUGCARD DB03066

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
10326-41-7

# ChEBI_ID:
341

# Chemical_Formula:
C3H6O3

# Chemical_IUPAC_Name:
(2R)-2-hydroxypropanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
D-Lactic Acid

# HET_ID:
DLA

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m1/s1

# InChI_Key:
InChIKey=JVTAAEKCZFNVCJ-UWTATZPHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00256

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3066

# Mechanism_Of_Action:
Not Available

# Melting_Point:
52.8 Â°C

# Molecular_Weight_Avg:
90.0779

# Molecular_Weight_Mono:
90.031694058

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1QH9

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.79

# Predicted_LogS:
0.79

# Predicted_Water_Solubility:
5.62e+02 g/l

# Primary_Accession_No:
DB03066

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
61503

# PubChem_Substance_ID:
46505962

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01215

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@@H](O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:52 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
3.83

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
S74078

# Drug_Target_1_GenBank_ID_Protein:
691747

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>699 bp
ATGGACTACATCAAGGGTATTGCCTTCGACCTTTACGGTACGCTGTTCGACGTCCATTCG
GTTGTCGGCCGATGCGACGAGGCGTTCCCGGGTCGCGGGCGCGAGATCAGCGCGCTGTGG
CGGCAAAAGCAGCTCGAGTACACATGGCTGCGAAGCCTGATGAATCGCTACGTTAACTTC
CAACAGGCGACCGAAGACGCGTTGCGGTTTACCTGCCGGCATCTTGGGCTCGATCTGGAT
GCGAGAACCCGCAGCACGCTTTGCGACGCGTACTTGCGGCTTGCACCGTTCAGCGAGGTG
CCCGATTCGCTACGCGAACTTAAGCGGCGCGGTCTGAAGCTCGCCATCCTGTCGAACGGC
TCGCCGCAGTCGATCGATGCCGTCGTGAGCCATGCGGGGCTGCGGGATGGATTCGACCAC
CTGCTCAGCGTCGATCCGGTACAGGTCTACAAACCCGATAACCGCGTGTATGAACTCGCG
GAGCAGGCGTTGGGGCTCGACCGATCGGCGATCCTGTTCGTGTCGTCGAACGCGTGGGAC
GCAACGGGGGCGCGCTACTTCGGCTTCCCGACATGCTGGATCAATCGGACCGGCAACGTC
TTTGAAGAGATGGGGCAGACACCCGACTGGGAGGTAACCAGCCTCCGCGCCGTGGTGGAG
CTGTTCGAGACGGCCGCCGGGAAGGCAGAAAAGGGCTGA

# Drug_Target_1_General_Function:
Involved in haloacid dehalogenas activity

# Drug_Target_1_General_References:
7490277	Kurihara T, Liu JQ, Nardi-Dei V, Koshikawa H, Esaki N, Soda K: Comprehensive site-directed mutagenesis of L-2-halo acid dehalogenase to probe catalytic amino acid residues. J Biochem (Tokyo). 1995 Jun;117(6):1317-22.
7944368	Nardi-Dei V, Kurihara T, Okamura T, Liu JQ, Koshikawa H, Ozaki H, Terashima Y, Esaki N, Soda K: Comparative studies of genes encoding thermostable L-2-halo acid dehalogenase from Pseudomonas sp. strain YL, other dehalogenases, and two related hypothetical proteins from Escherichia coli. Appl Environ Microbiol. 1994 Sep;60(9):3375-80.
8702766	Hisano T, Hata Y, Fujii T, Liu JQ, Kurihara T, Esaki N, Soda K: Crystal structure of L-2-haloacid dehalogenase from Pseudomonas sp. YL. An alpha/beta hydrolase structure that is different from the alpha/beta hydrolase fold. J Biol Chem. 1996 Aug 23;271(34):20322-30.
9614112	Li YF, Hata Y, Fujii T, Hisano T, Nishihara M, Kurihara T, Esaki N: Crystal structures of reaction intermediates of L-2-haloacid dehalogenase and implications for the reaction mechanism. J Biol Chem. 1998 Jun 12;273(24):15035-44.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2995

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
26177

# Drug_Target_1_Name:
(S)-2-haloacid dehalogenase

# Drug_Target_1_Number_of_Residues:
232

# Drug_Target_1_PDB_ID:
1JUD

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00702	Hydrolase

# Drug_Target_1_Protein_Sequence:
>(S)-2-haloacid dehalogenase
MDYIKGIAFDLYGTLFDVHSVVGRCDEAFPGRGREISALWRQKQLEYTWLRSLMNRYVNF
QQATEDALRFTCRHLGLDLDARTRSTLCDAYLRLAPFSEVPDSLRELKRRGLKLAILSNG
SPQSIDAVVSHAGLRDGFDHLLSVDPVQVYKPDNRVYELAEQALGLDRSAILFVSSNAWD
ATGARYFGFPTCWINRTGNVFEEMGQTPDWEVTSLRAVVELFETAAGKAEKG

# Drug_Target_1_Reaction:
(S)-2-haloacid + H2O = (R)-2-hydroxyacid + halide

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the hydrolytic dehalogenation of small (S)-2- haloalkanoic acids to yield the corresponding (R)-2- hydroxyalkanoic acids. Acts on acids of short chain lengths, C(2) to C(4), with inversion of configuration at C-2

# Drug_Target_1_SwissProt_ID:
Q53464

# Drug_Target_1_SwissProt_Name:
HAD_PSEUY

# Drug_Target_1_Synonyms:
2-haloalkanoic acid dehalogenase
EC 3.8.1.2
Halocarboxylic acid halidohydrolase
L-2-haloacid dehalogenase
L-DEX

# Drug_Target_1_Theoretical_pI:
5.72

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03066
